*****HOT STOCK REVERSAL SETTING UP IN AMEX:EGI , SET ALERT FOR BREAK ABOVE $0.33, SUCH SMALL CAPS MOVE ON NEWS FLOW, SO THE BUYING ACTIVITY IN THE PREVIOUS 2 SESSIONS ARE OF GREAT INTEREST. ********** COMPANY PROFILE Entrée Resources Ltd. operates as a mineral exploration company that focuses on the exploration, development, and acquisition of base metal...
The best way to analysis this is by looking at a few simple numbers. share price 1980 $5.13 share price 2007 $85 share price 2012 $42 share price 2019 $1 From a positive perspective the stock is staging somewhat of a recovery from sub$1 as inside buying and upside call buying has sparked some interest once again, unfortunately the stock still has a...
AS THE STATEMENT BELOW DETAILS, A LARGE MOVE WAS EXPECTED IN THE STOCK NEXT WEEK ON RATIFICATION OF THE MERGER, THE MEETING WAS ADJOURNED, SO A PULLBACK IS VERY LIKELY NEXT WEEK WHICH WILL BE A BUYING OPPORTUNITY. FLKS On June 14, 2019, Flex Pharma, Inc. (“Flex Pharma” or “FLKS”) held its special meeting of stockholders. The purpose of the special meeting is...
Today it has been reported by Reuters that Sony are under pressure from Third Point to spin of its semiconductor business which would unlock massive value for investors and CASH FOR THE COMPANY TO REINVEST. “Sony’s semiconductor business is dramatically underappreciated by the market despite its position as the global leader in image sensors with over 70% revenue...
The Greyscale Bitcoin Trust is a easy way to get invested in bitcoin and related coins. It takes the hassle of opening wallets etc away from the investor and gives exposure to the often confusing crypto markets. This is in our opionion a short term trade and something to hold as you are paying a premium for someone else doing the work. The fund has over 800mil in...
IT IS POSSIBLE THAT GRUB HAS ACTUALLY BUILT A BASE FROM WHICH TO FIND SOME CONSISTENCY IN THE PRICE ACTION. THE NEWS THAT AMZN WOULD NOT BE ENTERING THE SECTOR AS A COMPETITION DID ALSO GIVE THE STOCK A BOOST, BUT COMPETITION IS FIERCE AND PROFITS NON EXISTENT. THE CHART INDICATORS ARE BULLISH AND AS LONG AS $69 HOLDS IT REMAIN SO. AVERAGE ANALYSTS PRICE TARGET...
If you fancy a flutter, GERN could be a great place to start, option traders are expecting a move of up to $40 % on Monday as a result of the outcome from the Phase Data results been released tomorrow at the HOC conference. Like any Bio stock it is risky to trade but can be very rewarding,so play carefully. AVERAGE ANALYSTS PRICE TARGET $3.5 AVERAGE ANALYSTS...
The first quarter of 2018 AVGO had a similar downbeat report and earnings call, they stock sold of before hitting a all time high 1 year later. This time round the stock has rebounded 5% alone from the pre market lows, and has moved back above the 200ma which is a critical level, if it can close at these levels buyers will flock back in next week if the market...
======================== ZNZBF (Zanzibar Gold Inc.) Alert Price: $0.1150 Float: 13.69M Website | Recent News ======================== Members, We plan on ending this already profitable week of trading with something huge! We've just identified an exciting opportunity in the gold sector. We have several reasons to believe that the entire gold...
*********This is truly speculative as there is no fundamental reason for this to be attracting attention, but it could very likely spike in the coming days. This is a pre clinical company so news has a major impact on price.***** COMPANY PROFILE Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development,...
The stock of NKTR has been setting up nicely for a breakout and June 13th could be the day it happens, as the company will be hosting a analysts conference call to discuss trial results/data. Keep on strong watch for explosive moves. AVERAGE ANALYSTS PRICE TARGET $69.50 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT SHORT INTEREST 12.65% P/E RATIO 9.54 Nektar...
*******ALERTED TO CAPR ON SPECULATION AND RUMOR WITH HIGH VOLUME AND PRICE SPIKE TO CONFIRM INTEREST, ON CLOSE WATCH FOR COMING DAYS***** AVERAGE ANALYSTS PRICE TARGET $35 AVERAGE ANALYSTS RECOMMENDATION COMPANY PROFILE Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the...
OPTIONS TRADES ARE A PRETTY GOOD TELL ON THE FUTURE OF A STOCK, IN THE CASE OF SNSS OPTIONS TRADED TODAY WERE OF INTEREST GIVEN THE FACT THE COMPANY WILL BE RELEASING DATA IN THE COMING DAYS. WITH A STRIKE PRICE OF $1 THEY PREDICT A UPSIDE POTENTIAL OF 40% BEFORE JUNE 21ST, THAT IS QUITE A NICE RISE FROM THE CURRENT LEVEL AND QUICK GAIN. SOMEONE KNOWS SOMETHING. ...
===================== GDET ( GD Entertainment & Technology, Inc.) Alert Price: $0.0069 Chart Analysis Goldman Price Target: $0.06 Goldman Small Cap Research Report Website | Recent News Ecommerce: www.thegreeneryco.com ======================== Members, Earlier today we promised you an explosive subpenny alert with massive upside potential. In...
Sine the 13th may when President and CEO DR Thomas Cannell conducted the company's earnings call, investors are buoyed by what he had to say and the future prospects, with upcoming meetings with the FDA this could be a blowout stock in the weeks to come. Average analyst estimate BUY Average analysts price target $3.50 Company Description Sesen Bio, Inc....
*********************BREAKOUT TODAY ON FDA APPROVAL****** Motus GI Holdings, Inc, a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the second-generation Pure-Vu® System (“Pure-Vu® GEN2”) to...
********KEEP ON THE WATCHLIST FOR BREAKOUT, IMPROVED TRIAL RESULTS RELEASED, WITH CONFERENCE CALL TO FOLLOW LATER IN THE DAY******* Achieve Life Sciences, Inc. ACHV, clinical-stage pharmaceutical company focused on nicotine addiction, today announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the...
*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...